Skip to content

Morphofunctional Lung Analysis by PET and CT After Lung Transplantation

Morphofunctional Lung Analysis by Positron Emission Tomography and Computed Tomography After Lung Transplantation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01746914
Enrollment
30
Registered
2012-12-11
Start date
2013-01-31
Completion date
2016-01-31
Last updated
2016-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disorder Related to Lung Transplantation

Brief summary

72 hours after lung transplantation, patients undergo a positron emission tomography (PET) scan and a computed tomography (CT) scan in order to analyse lung function and morphology. Aim of the study is to analyse complications onset (in particular primary graft dysfunction), and evaluate 90 days mortality after lung transplantation.

Detailed description

Pulmonary transplantation is considered as a lifesaving procedure in end-stage pulmonary disease. However morbidity and mortality after lung transplantation are still significant. Primary graft dysfunction (PGD) is the main cause of early death. PGD is similar to acute lung injury (ALI)/ acute respiratory distress syndrome (ARDS): oxygenation is compromised, pulmonary compliance is decreased, chest Rx shows several infiltrates, and alveolar damage is present. 25% of patients develops PGD within 72 hours from transplantation and 30 days mortality is eight times higher in patients who develop PGD. 72 hours after lung transplantation, patients, whose clinical condition allow to bring them to nuclear medicine department, will undergo pulmonary computed tomography (CT) to study lung morphology and measure lung recruitability and positron emission tomography (PET) to study lung functionality and estimate lung inflammation. Aim of this study is to investigate the onset of PGD and other complications and to determine 72 hours and 90 days mortality after lung transplantation.

Interventions

None listed

Sponsors

Policlinico Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* lung transplantation * ≥ 18 years

Exclusion criteria

* \< 18 years * patient' s clinical conditions not allowing patient transport from ICU to Nuclear Medicine Unit

Design outcomes

Primary

MeasureTime frame
Number of patients aliveup to 90 days from transplantation

Secondary

MeasureTime frame
incidence of primary graft dysfunction72 hours and 90 days after transplantation
incidence of complications other than primary graft dysfunction72 hours and 90 days

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026